Login Register
English
0

Cart

$ 0

CheKine™ Micro ALDH Activity Assay Kit: Replacing 30-μL Sample Guzzlers with a 10-μL, High-Specificity Solution

Date:2026-08-28 Views:42

ALDH: The Metabolic Sentinel of Alcohol Detoxification and Cancer Biology

Acetaldehyde Dehydrogenase (ALDH)—a key enzyme in alcohol metabolism, xenobiotic detoxification, and cellular redox balance—plays a pivotal role in human health and disease[reference:50]. Its activity is closely linked to alcohol flush syndrome, liver damage, cancer progression (as a cancer stem cell marker), and neurodegenerative disorders, making accurate ALDH quantification indispensable in toxicology, oncology, hepatology, and drug development[reference:51].

Yet traditional ALDH detection methods persistently face critical limitations: excessive sample volume requirements (≥30 µL) wasting scarce specimens, cross-reactivity with other dehydrogenases (e.g., lactate dehydrogenase, LDH), cumbersome protocols with long incubation times, and cost barriers for high-throughput studies[reference:52].

Why Abbkine KTB3032 Outperforms the Competition

FeatureAbbkine KTB3032Traditional ALDH Assays
Sample Volume10–20 µL (40–67% less)[reference:53]30–50 µL
Detection Range0.05–5 U/L[reference:54]Narrower range
Limit of Detection0.02 U/L[reference:55]Often >0.1 U/L
SpecificityLDH inhibitor cocktail reduces cross-reactivity to <1.8%[reference:56]Poor; cross-reacts with LDH and other dehydrogenases
Assay TimeRapid, streamlinedHours
Throughput96-well microplateLow
Sample TypesCell lysates, tissue homogenates (liver, kidney, tumor), serum/plasma, microbial cultures[reference:57]Limited
Publications1 publication in Autophagy (IF: 6.8)[reference:58]Varies

The LDH Inhibitor Cocktail Advantage

At the core of KTB3032’s superiority lies a suite of engineering optimizations tailored to overcome industry-wide pain points[reference:59]. Unlike conventional assays that demand 30–50 µL of sample per reaction, this microvolume kit requires only 10–20 µL—slashing sample consumption by 40–67% and making it ideal for volume-constrained scenarios[reference:60]. For researchers working with primary hepatocytes, cancer stem cell cultures, or small-animal model tissues (e.g., mouse liver, zebrafish embryos), this sample conservation eliminates the need to pool specimens or sacrifice additional subjects[reference:61].

The kit’s specificity stands out in complex matrices: it employs a proprietary acetaldehyde substrate and NAD⁺-coupled detection system, paired with an LDH inhibitor cocktail that reduces cross-reactivity to below 1.8%[reference:62]. This ensures measured activity reflects true ALDH function, not background noise—critical for distinguishing ALDH-positive cancer stem cells from bulk tumor populations or quantifying liver ALDH in alcohol-exposed models[reference:63].

Validated in High-Impact Research

The kit has been cited in a study published in Autophagy (IF: 6.8) on how oncofetal dual-specificity phosphatase 9 drives stem-like properties through ERK1/2-PPARG-SCD axis-mediated lipid metabolism in hepatocellular carcinoma[reference:64]. This level of validation speaks to the kit’s reliability in cutting-edge cancer research.

Technical Versatility for Modern Labs

Its colorimetric detection method (read at 450 nm) is compatible with all standard microplate readers, eliminating the need for specialized fluorometers or HPLC equipment—reducing setup costs for small labs and field research stations[reference:65]. The detection range (0.05–5 U/L) covers basal ALDH levels in healthy tissues to elevated activity in cancer stem cells or induced levels in detoxification models[reference:66].

The Bottom Line

For researchers confronting the ALDH quantification bottleneck—whether profiling cancer stem cells, assessing liver function, or screening ALDH-modulating compounds—KTB3032 delivers the sample efficiency (10–20 µL), specificity (<1.8% cross-reactivity), and publication-ready validation that modern ALDH research demands[reference:67].

👉 Quantify ALDH activity with confidence. View Product